Jehoshaphat Research is short Adapthealth Corp (NASDAQ:AHCO). Q2 2021 hedge fund letters, conferences and more We believe that AdaptHealth (NASDAQ:AHCO), a roll-up of roll-ups with excessive debt, is deceiving the investor community via its financial reporting practices. While management claims (and consensus estimates reflect) an organic growth trajectory of 8-10%, AHCO is in fact experiencing […]
The post Not Just A Roll-Up, But A Coverup: Is AHCO The Next MDCA? appeared first on ValueWalk.
Jump To The Original Source